Hartmann S, Banys-Paluchowski M, Berger T, Ditsch N, Stickeler E, de Boniface J, Gentilini OD, Schroth J, Karadeniz Cakmak G, Rubio IT, Gasparri ML, Kontos M, Bonci EA, Niinikoski L, Murawa D, Kadayaprath G, Pinto D, Peintinger F, Schlichting E, Dostalek L, Nina H, Valiyeva H, Vanhoeij M, Perhavec A, Zippel D et al. (2025)
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)
Eur J Surg Oncol, 51 (9), 110253 (in press)
DOI 10.1016/j.ejso.2025.110253, PubMed 40587927

Frich PS, Sigstad E, Berstad AE, Opsahl EM, Fagerlid KH, Grøholt KK, Bjøro T, Hole KH, Flinder LI (2025)
Ethanol Ablation of Metastatic Lymph Nodes in Patients with Papillary Thyroid Carcinoma - Predictors of Clinical Outcome
J Clin Endocrinol Metab (in press)
DOI 10.1210/clinem/dgaf298, PubMed 40405530

Banys-Paluchowski M, Hartmann S, Basali T, Gasparri ML, de Boniface J, Gentilini OD, Cakmak GK, Ditsch N, Stickeler E, Schlichting E, Rubio I, Peintinger F, Untch M, Mau C, Federspiel FK, Bucher S, Ramaker K, Paluchowski P, Bauer L, Riemer S, Langanke D, Leuf TD, Schnabel J, von Abel E, Solbach C et al. (2025)
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
Breast Cancer Res Treat, 211 (1), 203-211
DOI 10.1007/s10549-025-07635-4, PubMed 39976867